These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Update on the evaluation and treatment of osteogenesis imperfecta. Harrington J, Sochett E, Howard A. Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022 [Abstract] [Full Text] [Related]
6. EMQN best practice guidelines for the laboratory diagnosis of osteogenesis imperfecta. van Dijk FS, Byers PH, Dalgleish R, Malfait F, Maugeri A, Rohrbach M, Symoens S, Sistermans EA, Pals G. Eur J Hum Genet; 2012 Jan; 20(1):11-9. PubMed ID: 21829228 [Abstract] [Full Text] [Related]
7. [Oesteogenesis imperfecta--genetics, diagnosis and medical treatment]. Brixen KT, Illum NO, Hansen B, Lund AM, Mosekilde L. Ugeskr Laeger; 2007 Jan 01; 169(1):30-4. PubMed ID: 17217883 [Abstract] [Full Text] [Related]
8. Current Overview of Osteogenesis Imperfecta. Deguchi M, Tsuji S, Katsura D, Kasahara K, Kimura F, Murakami T. Medicina (Kaunas); 2021 May 10; 57(5):. PubMed ID: 34068551 [Abstract] [Full Text] [Related]
9. Decreased fracture rate, pharmacogenetics and BMD response in 79 Swedish children with osteogenesis imperfecta types I, III and IV treated with Pamidronate. Lindahl K, Kindmark A, Rubin CJ, Malmgren B, Grigelioniene G, Söderhäll S, Ljunggren Ö, Åström E. Bone; 2016 Jun 10; 87():11-8. PubMed ID: 26957348 [Abstract] [Full Text] [Related]
10. Diagnosis of fetal osteogenesis imperfecta by multidisciplinary assessment: a retrospective study of 10 cases. Wu Q, Wang W, Cao L, Sun L, Xu Y, Zhong X. Fetal Pediatr Pathol; 2015 Feb 10; 34(1):57-64. PubMed ID: 25289482 [Abstract] [Full Text] [Related]
11. Intravenous pamidronate in osteogenesis imperfecta type VII. Cheung MS, Glorieux FH, Rauch F. Calcif Tissue Int; 2009 Mar 10; 84(3):203-9. PubMed ID: 19137231 [Abstract] [Full Text] [Related]
12. [Osteogenesis imperfecta--a congenital brittleness of bones]. Kaitila I, Kuurila K, Kallio P. Duodecim; 2001 Mar 10; 117(21):2195-202. PubMed ID: 12184207 [No Abstract] [Full Text] [Related]
15. Osteogenesis imperfecta and its molecular diagnosis by determination of mutations of type I collagen genes. Tedeschi E, Antoniazzi F, Venturi G, Zamboni G, Tatò L. Pediatr Endocrinol Rev; 2006 Sep 16; 4(1):40-6. PubMed ID: 17021582 [Abstract] [Full Text] [Related]
16. Advances in the Classification and Treatment of Osteogenesis Imperfecta. Thomas IH, DiMeglio LA. Curr Osteoporos Rep; 2016 Feb 16; 14(1):1-9. PubMed ID: 26861807 [Abstract] [Full Text] [Related]
17. [Osteogenesis imperfecta]. Schuh A, Hönle W, Effenberger H. MMW Fortschr Med; 2009 Nov 26; 151(48):38, 40. PubMed ID: 20085061 [No Abstract] [Full Text] [Related]
18. Scoliosis in osteogenesis imperfecta caused by COL1A1/COL1A2 mutations - genotype-phenotype correlations and effect of bisphosphonate treatment. Sato A, Ouellet J, Muneta T, Glorieux FH, Rauch F. Bone; 2016 May 26; 86():53-7. PubMed ID: 26927310 [Abstract] [Full Text] [Related]
19. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Trejo P, Rauch F. Osteoporos Int; 2016 Dec 26; 27(12):3427-3437. PubMed ID: 27492436 [Abstract] [Full Text] [Related]